ES8406070A1 - Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica - Google Patents
Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmicaInfo
- Publication number
- ES8406070A1 ES8406070A1 ES527091A ES527091A ES8406070A1 ES 8406070 A1 ES8406070 A1 ES 8406070A1 ES 527091 A ES527091 A ES 527091A ES 527091 A ES527091 A ES 527091A ES 8406070 A1 ES8406070 A1 ES 8406070A1
- Authority
- ES
- Spain
- Prior art keywords
- piperidindiona
- miocardio
- protective
- procedure
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000003288 anthiarrhythmic effect Effects 0.000 title 1
- 230000001681 protective effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000005458 piperidinediones Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE PIPERIDINDIONAS DE FORMULA (I), EN LAS QUE N VALE 2 O 3; Y R Y R1-R5 PUEDEN SER VARIOS RADICALES; COMPUESTOS QUE TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIARRITMICA.CONSISTE EN LA ALQUILACION DE PIRIDILACETONITRILO CON UN COMPUESTO DE FORMULA HAL(CH2)N-N(R)2, EN PRESENCIA DE UNA BASE; SEGUIDA DEL TRATAMIENTO CON UN NITRILO BAB- NO SATURADO DE FORMULA R1R2CFCR3CN, EN LAS QUE HAL ES HALOGENO Y LOS DEMAS SIMBOLOS SON LOS MISMOS QUE EN LA FORMULA (I). EL COMPUESTO OBTENIDO SE CICLA EN MEDIO ACIDO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8218706A FR2535721A1 (fr) | 1982-11-08 | 1982-11-08 | Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives |
Publications (2)
Publication Number | Publication Date |
---|---|
ES527091A0 ES527091A0 (es) | 1984-07-01 |
ES8406070A1 true ES8406070A1 (es) | 1984-07-01 |
Family
ID=9279000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES527091A Expired ES8406070A1 (es) | 1982-11-08 | 1983-11-08 | Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica |
Country Status (29)
Country | Link |
---|---|
US (1) | US4721710A (es) |
EP (1) | EP0110755B1 (es) |
JP (1) | JPS59161377A (es) |
KR (1) | KR900006721B1 (es) |
AT (1) | ATE22561T1 (es) |
AU (1) | AU565519B2 (es) |
CA (1) | CA1221967A (es) |
CS (1) | CS244681B2 (es) |
DD (3) | DD219770A5 (es) |
DE (1) | DE3366623D1 (es) |
DK (1) | DK511383A (es) |
ES (1) | ES8406070A1 (es) |
FI (1) | FI79536C (es) |
FR (1) | FR2535721A1 (es) |
GR (1) | GR78747B (es) |
HU (1) | HU191494B (es) |
IE (1) | IE56209B1 (es) |
IL (1) | IL70099A (es) |
MA (1) | MA19948A1 (es) |
NO (1) | NO159852C (es) |
NZ (1) | NZ206177A (es) |
OA (1) | OA07582A (es) |
PH (1) | PH20421A (es) |
PL (3) | PL140992B1 (es) |
PT (1) | PT77607B (es) |
SG (1) | SG1989G (es) |
SU (3) | SU1333237A3 (es) |
YU (3) | YU221183A (es) |
ZA (1) | ZA838065B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4668689A (en) * | 1984-07-19 | 1987-05-26 | National Research Development Corporation | Glutarimide derivatives for treating oestrogen-dependent tumors |
US5238947A (en) * | 1990-04-12 | 1993-08-24 | University Of Georgia Research Foundation, Inc. | Synthetic piperidinediones with cytostatic activity |
US5463063A (en) * | 1993-07-02 | 1995-10-31 | Celgene Corporation | Ring closure of N-phthaloylglutamines |
DE19703763C1 (de) * | 1997-02-01 | 1998-10-01 | Gruenenthal Gmbh | Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione |
JP5974084B2 (ja) | 2011-05-17 | 2016-08-23 | プリンシピア バイオファーマ インコーポレイテッド | チロシンキナーゼ阻害剤 |
KR102052670B1 (ko) | 2011-05-17 | 2019-12-06 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 키나아제 저해제 |
US9376438B2 (en) | 2011-05-17 | 2016-06-28 | Principia Biopharma, Inc. | Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors |
SMT201900344T1 (it) | 2012-09-10 | 2019-07-11 | Principia Biopharma Inc | Composti di pirazolopirimidina come inibitori di chinasi |
US8957080B2 (en) | 2013-04-09 | 2015-02-17 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
BR112016018948B1 (pt) | 2014-02-21 | 2023-01-17 | Principia Biopharma Inc | Uso de composto ou sal farmaceuticamente aceitável, ácido sulfônico ou sal de ácido carboxílico de composto, forma amorfa de sal farmaceuticamente aceitável de composto, composição farmacêutica e respectivo uso |
EP3233103B1 (en) | 2014-12-18 | 2020-10-14 | Principia Biopharma Inc. | Treatment of pemphigus |
MA42242A (fr) | 2015-06-24 | 2018-05-02 | Principia Biopharma Inc | Inhibiteurs de la tyrosine kinase |
CN115054586B (zh) | 2016-06-29 | 2024-08-02 | 普林斯匹亚生物制药公司 | 改性的释放制剂 |
IL291994A (en) | 2019-10-14 | 2022-06-01 | Principia Biopharma Inc | Methods for treating immune thrombocytopenia by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2664424A (en) * | 1953-12-29 | Dioxo-piperidines | ||
GB1455687A (en) * | 1972-12-28 | 1976-11-17 | Aspro Nicholas Ltd | Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines |
FR2467200A1 (fr) * | 1979-10-11 | 1981-04-17 | Clin Midy | Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire |
-
1982
- 1982-11-08 FR FR8218706A patent/FR2535721A1/fr active Granted
-
1983
- 1983-10-28 ZA ZA838065A patent/ZA838065B/xx unknown
- 1983-10-31 IL IL70099A patent/IL70099A/xx unknown
- 1983-11-02 AU AU20898/83A patent/AU565519B2/en not_active Ceased
- 1983-11-04 DE DE8383402142T patent/DE3366623D1/de not_active Expired
- 1983-11-04 GR GR72874A patent/GR78747B/el unknown
- 1983-11-04 AT AT83402142T patent/ATE22561T1/de not_active IP Right Cessation
- 1983-11-04 EP EP83402142A patent/EP0110755B1/fr not_active Expired
- 1983-11-04 PT PT77607A patent/PT77607B/pt not_active IP Right Cessation
- 1983-11-04 IE IE2581/83A patent/IE56209B1/xx unknown
- 1983-11-05 SU SU833661804A patent/SU1333237A3/ru active
- 1983-11-07 NO NO834057A patent/NO159852C/no unknown
- 1983-11-07 DD DD83256411A patent/DD219770A5/de not_active IP Right Cessation
- 1983-11-07 DD DD83270121A patent/DD229402A5/de not_active IP Right Cessation
- 1983-11-07 NZ NZ206177A patent/NZ206177A/en unknown
- 1983-11-07 MA MA20168A patent/MA19948A1/fr unknown
- 1983-11-07 DD DD83270120A patent/DD229407A5/de not_active IP Right Cessation
- 1983-11-08 CS CS838220A patent/CS244681B2/cs unknown
- 1983-11-08 PL PL1983249749A patent/PL140992B1/pl unknown
- 1983-11-08 FI FI834087A patent/FI79536C/fi not_active IP Right Cessation
- 1983-11-08 HU HU833827A patent/HU191494B/hu not_active IP Right Cessation
- 1983-11-08 CA CA000440675A patent/CA1221967A/en not_active Expired
- 1983-11-08 OA OA58153A patent/OA07582A/xx unknown
- 1983-11-08 ES ES527091A patent/ES8406070A1/es not_active Expired
- 1983-11-08 JP JP58209772A patent/JPS59161377A/ja active Pending
- 1983-11-08 PL PL1983249750A patent/PL140021B1/pl unknown
- 1983-11-08 PH PH29800A patent/PH20421A/en unknown
- 1983-11-08 DK DK511383A patent/DK511383A/da not_active Application Discontinuation
- 1983-11-08 PL PL1983244462A patent/PL139946B1/pl unknown
- 1983-11-08 YU YU02211/83A patent/YU221183A/xx unknown
- 1983-11-08 KR KR1019830005288A patent/KR900006721B1/ko not_active Expired
-
1984
- 1984-09-06 SU SU843786907A patent/SU1316558A3/ru active
- 1984-09-06 SU SU843786916A patent/SU1333238A3/ru active
-
1985
- 1985-11-26 YU YU01841/85A patent/YU184185A/xx unknown
- 1985-11-26 YU YU01842/85A patent/YU184285A/xx unknown
-
1986
- 1986-03-10 US US06/838,255 patent/US4721710A/en not_active Expired - Fee Related
-
1989
- 1989-01-11 SG SG19/89A patent/SG1989G/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8406070A1 (es) | Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica | |
ES525786A0 (es) | Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina | |
IL61285A0 (en) | 2-hydroxyalkyl-3,4,k-trihydroxy-piperidine compounds, their production and pharmaceutical compositions containing them | |
IL73320A0 (en) | Purine derivatives and pharmaceutical compositions containing them | |
ES8706148A1 (es) | Un procedimiento para preparar nuevos derivados de carbapenem. | |
IT7827850A0 (it) | Composizioni stabilizzate alla luce uv, contenenti 1,5-diazacicloalcani e 2-cheto-1,5-diazacicloalcani sostituiti come composti di nuovo tipo e sintesi di tali composti. | |
DE68922344D1 (de) | Herstellung von Enantiomeren des Dropropizins. | |
HUT39445A (en) | Herbicides containing as reagent derivatives of benzodisultam and process for production of the reagents | |
JPS57200370A (en) | 1-acyl group substituted-4-hydroxyalkylhomopiperazine derivative | |
ES8305748A1 (es) | Procedimiento para la obtencion de sulfenamidas. | |
ATE23340T1 (de) | 3-alkylthio-2-0-carbamoylpropan-1,2-diol-1-0phosphocholine und verfahren zu ihrer herstellung. | |
HU905030D0 (en) | Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds | |
SE8106359L (sv) | 5,6,7,8-tetrahydro-1,6-naftyridinderivat och sett att framstella desamma | |
ES8402821A1 (es) | Procedimiento de obtencion de las feniloxoalcoil piperidinas. | |
JPS53124277A (en) | 1-substed-(1,2-diphenylpropyl)piperazines | |
ATE108783T1 (de) | 2-imino-6-polyfluoralkyl-3-heterocyclylalkyl- benzothiazolinderivate, ihre herstellung und sie enthaltende arzneimittel. |